{
    "Trade/Device Name(s)": [
        "NMR LipoProfile-2 Assay",
        "NMR Profiler Instrument Test System",
        "NMR Profiler and NMR LipoProfile Test"
    ],
    "Submitter Information": "LipoScience, Incorporated",
    "510(k) Number": "K063841",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020724",
        "K971324",
        "K971162"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MRR",
        "JJY",
        "CDT",
        "LBS",
        "JIT"
    ],
    "Summary Letter Date": "July 28, 2008",
    "Summary Letter Received Date": "April 24, 2008",
    "Submission Date": "April 23, 2008",
    "Regulation Number(s)": [
        "21CFR862.1475",
        "21CFR862.1705",
        "21CFR862.1660",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system",
        "Triglyceride test system",
        "Quality control material",
        "Calibrator"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "LDL particle number (LDL-P)",
        "HDL cholesterol (HDL-C)",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "NMR LipoTube",
        "Plain red-top blood collection tube",
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "NMR Profiler"
    ],
    "Method(s)/Technology(ies)": [
        "Nuclear magnetic resonance (NMR) spectroscopy"
    ],
    "Methodologies": [
        "Spectral deconvolution analysis",
        "Physical measurement",
        "Automated calculation via proprietary algorithm"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "System",
        "Calibrator",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for NMR LipoProfile-2 Assay and NMR Profiler Test System for quantification of LDL particle number, HDL cholesterol, and triglycerides in serum and plasma using NMR spectroscopy.",
    "Indications for Use Summary": "Quantitative measurement of LDL particle number, HDL cholesterol, and triglycerides in serum and plasma using NMR spectroscopy to aid in the management of lipoprotein disorders associated with cardiovascular disease.",
    "fda_folder": "Clinical Chemistry"
}